Gene · 23521
NIH grants2,185
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,181 to 1,200 of 2,185
Download this page as JSON| Grant | Title | RPL13A papers | Newest fiscal year |
|---|---|---|---|
| R01MH102418 | Autism-linked endosomal mechanisms in neuronal arborization and connectivity | 1 | 2018 |
| R01NS062856 | Mechanisms of Gene Silencing of Friedreich's Ataxia | 1 | 2018 |
| R01NS077926 | Huntingtin proline-rich region modulation of Huntington's disease pathogenesis | 1 | 2018 |
| R01NS087913 | Metabolism Informs Intertumoral & Intratumoral Heterogeneity | 1 | 2018 |
| R01NS089272 | Energy Stress in Brain Tumor Initiating Stem Cells | 1 | 2018 |
| R03ES027945 | Genome-wide Analysis of the Formation and Repair of DNA Alkylation Lesions | 1 | 2018 |
| R21AG054206 | A Novel RNA Binding Protein Modulates Tau Pathology | 1 | 2018 |
| R21AG055325 | DUOX1 Silencing in Age-Related COPD | 1 | 2018 |
| R21AG056819 | Regenerative Enhancement of Aged Chondrocytes via Cytoskeletal Modulation | 1 | 2018 |
| R21AI126368 | Innate Immunity and Gender Differences in Melanoma | 1 | 2018 |
| R21CA213535 | Engineering Antibody Drug Conjugates To Target P53-Defective Triple Negative Breast Cancer | 1 | 2018 |
| R21EY027389 | Eph-ephrin signaling in the lens | 1 | 2018 |
| R21MH115392 | Convergent Cellular Mechanisms Governed by UBE3A and NHEs in Neurons | 1 | 2018 |
| R21NS099606 | The role of TLR4-dependent sterile inflammation in mediating adverse outcomes after SAH | 1 | 2018 |
| R24DK092760 | Customized stem cells for clinical application in blood disorders | 1 | 2018 |
| R33AI116218 | Evaluating HIV expression and latency in blood and tissues at the single cell level | 1 | 2018 |
| R37AR042455 | Maternal Autoantibodies: Pathogenesis of Neonatal Lupus | 1 | 2018 |
| R37GM069530 | E3-mediated Ubiquitin-like Protein Ligation | 1 | 2018 |
| R41AI132047 | Therapeutic antibodies for treatment of hantavirus cardiopulmonary syndrome | 1 | 2018 |
| R43CA221414 | Development of IG7 as an enhancer of anti-PD-1 cancer immunotherapy | 1 | 2018 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23521/grants?page=60